{
     "PMID": "27757991",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20180201",
     "LR": "20180201",
     "IS": "1098-1136 (Electronic) 0894-1491 (Linking)",
     "VI": "65",
     "IP": "1",
     "DP": "2017 Jan",
     "TI": "Cannabinoids prevent the amyloid beta-induced activation of astroglial hemichannels: A neuroprotective mechanism.",
     "PG": "122-137",
     "LID": "10.1002/glia.23080 [doi]",
     "AB": "The mechanisms involved in Alzheimer's disease are not completely understood and how astrocytes and their gliotransmission contribute to this neurodegenerative disease remains to be fully elucidated. Previous studies have shown that amyloid-beta peptide (Abeta) induces neuronal death by a mechanism that involves the excitotoxic release of ATP and glutamate associated to astroglial hemichannel opening. We have demonstrated that synthetic and endogenous cannabinoids (CBs) reduce the opening of astrocyte Cx43 hemichannels evoked by activated microglia or inflammatory mediators. Nevertheless, whether CBs could prevent the astroglial hemichannel-dependent death of neurons evoked by Abeta is unknown. Astrocytes as well as acute hippocampal slices were treated with the active fragment of Abeta alone or in combination with the following CBs: WIN, 2-AG, or methanandamide (Meth). Hemichannel activity was monitored by single channel recordings and by time-lapse ethidium uptake while neuronal death was assessed by Fluoro-Jade C staining. We report that CBs fully prevented the hemichannel activity and inflammatory profile evoked by Abeta in astrocytes. Moreover, CBs fully abolished the Abeta-induced release of excitotoxic glutamate and ATP associated to astrocyte Cx43 hemichannel activity, as well as neuronal damage in hippocampal slices exposed to Abeta. Consequently, this work opens novel avenues for alternative treatments that target astrocytes to maintain neuronal function and survival during AD. GLIA 2016 GLIA 2017;65:122-137.",
     "CI": [
          "(c) 2016 Wiley Periodicals, Inc."
     ],
     "FAU": [
          "Gajardo-Gomez, Rosario",
          "Labra, Valeria C",
          "Maturana, Carola J",
          "Shoji, Kenji F",
          "Santibanez, Cristian A",
          "Saez, Juan C",
          "Giaume, Christian",
          "Orellana, Juan A"
     ],
     "AU": [
          "Gajardo-Gomez R",
          "Labra VC",
          "Maturana CJ",
          "Shoji KF",
          "Santibanez CA",
          "Saez JC",
          "Giaume C",
          "Orellana JA"
     ],
     "AD": "Departamento de Neurologia; Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile. Departamento de Neurologia; Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile. Departamento de Neurologia; Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile. Departamento de Fisiologia, Pontificia Universidad Catolica de Chile, Santiago de Chile, Chile and Instituto Milenio, Centro Interdisciplinario de Neurociencias de Valparaiso, Chile. Departamento de Neurologia; Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile. Departamento de Fisiologia, Pontificia Universidad Catolica de Chile, Santiago de Chile, Chile and Instituto Milenio, Centro Interdisciplinario de Neurociencias de Valparaiso, Chile. Center for Interdisciplinary Research in Biology, College de France/Centre National de la Recherche Scientifique, Unite Mixte de Recherche 7241, Institut National de la Sante et de la Recherche Medicale U1050, Paris Cedex 05, France. Departamento de Neurologia; Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article"
     ],
     "DEP": "20161019",
     "PL": "United States",
     "TA": "Glia",
     "JT": "Glia",
     "JID": "8806785",
     "RN": [
          "0 (Amyloid beta-Peptides)",
          "0 (Cannabinoids)",
          "0 (Connexins)",
          "3KX376GY7L (Glutamic Acid)"
     ],
     "SB": "IM",
     "MH": [
          "Amyloid beta-Peptides/*pharmacology",
          "Animals",
          "Animals, Newborn",
          "Astrocytes/*drug effects/metabolism",
          "Cannabinoids/*pharmacology",
          "Cell Death/drug effects",
          "Cells, Cultured",
          "Connexins/metabolism",
          "Glutamic Acid/metabolism",
          "Hippocampus/*drug effects/metabolism",
          "Mice",
          "Neurons/*drug effects/metabolism"
     ],
     "OTO": [
          "NOTNLM"
     ],
     "OT": [
          "alzheimer",
          "connexin43",
          "glia",
          "neuroinflammation",
          "neuron"
     ],
     "EDAT": "2016/10/21 06:00",
     "MHDA": "2018/02/02 06:00",
     "CRDT": [
          "2016/10/21 06:00"
     ],
     "PHST": [
          "2016/08/03 00:00 [received]",
          "2016/09/13 00:00 [revised]",
          "2016/09/19 00:00 [accepted]",
          "2016/10/21 06:00 [pubmed]",
          "2018/02/02 06:00 [medline]",
          "2016/10/21 06:00 [entrez]"
     ],
     "AID": [
          "10.1002/glia.23080 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Glia. 2017 Jan;65(1):122-137. doi: 10.1002/glia.23080. Epub 2016 Oct 19.",
     "term": "hippocampus"
}